Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 121-132

  Locatelli, Francesco ^a   Pisoni, Ronald L ^b   Combe, Christian ^c   Bommer, Juergen ^d   Andreucci, Vittorio E ^e   Piera, Luis ^f   Greenwood, Roger ^g   Feldman, Harold I ^h   Port, Friedrich K ^b   Held, Philip J ^b  

^a A MANZONI HOSPITAL   (Italy)

^b Univ Ren Res and Educ Assoc   (United States)

^c HÔPITAL SAINT ANDRÉ   (France)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g LISTER HOSPITAL   (United Kingdom)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anaemia; Chronic kidney disease; Haemodialysis; Morbidity; Mortality; rHuEpo

Indexed keywords

FERRIC HYDROXIDE; FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; IRON; MALTOFER; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL OBSERVATION; CLINICAL PRACTICE; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; FRANCE; GERMANY; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; ITALY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK ASSESSMENT; SPAIN; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

ANEMIA; CROSS-SECTIONAL STUDIES; ERYTHROPOIETIN, RECOMBINANT; EUROPE; FEMALE; HEMATINICS; HUMANS; IRON COMPOUNDS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 9144264827     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg458     Document Type: Article

References (26)

1. Young EW, Goodkin DA, Mapes DL et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000; 57 [Suppl 74]: S74-S81
2. Port FK, Orzol SM, Held PJ, Wolfe RA. Trends in treatment and survival for hemodialysis patients in the United States. Am J Kidney Dis 1998; 31: S34-S38
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end stage renal disease. Am J Kidney Dis 1998; 31: 53-61
4. Levin A, Thompson CR, Ethier J et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-134
5. O'Riordan E, Foley RN. Effects of anaemia on cardiovascular status. Nephrol Dial Transplant 2000; 15 [Suppl 3]: 19-22
6. Foley RN, Parfrey PS, Morgan J et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325-1335
7. Collins AJ. Influence of target haemoglobin in dialysis patients on morbidity and mortality. Kidney Int 2002; 80 [Suppl 2000]: 44-48
8. Parfrey P. Anaemia in chronic renal disease: lessons learned since Seville 1994. Nephrol Dial Transplant 2001; 16 [Suppl 7]: 41-45
9. Besarab A, Bolton W, Browne JK et al. The effects of normal as compared with low hematocrit in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-590
10. Pascual J, Teruel JL, Moya JL et al. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 1991; 35: 280-287
11. McMahon LP, McKenna MJ, Sangkabutra T et al. Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients. Nephrol Dial Transplant 1999; 14: 1182-1187
12. Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. J Am Med Assoc 1990; 263: 825-830
13. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Br Med J 1990; 3: 573-578
14. Painter P, Moore G, Carlson et al. Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am J Kidney Dis 2002; 39: 257-265
15. Lundin AP, Akerman MJ, Chesler RM et al. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 1991; 58: 315-319
16. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 2001; 11: 335-342
17. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 1999; 14 [Suppl 5]: 1-50
18. National Kidney Foundation. K/DOQI Clinical Practice Guidelines. 2000 update. Am J Kidney Dis 2001; 37 [Suppl 1]: S1-S238
19. Berthoux F, Lones E, Gellert R et al. Epidemiology data of treated end-stage renal failure in the European Union (EU) during the year 1995: Report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999; 14: 2332-2342
20. Klein JP, Moeschberger ML. Survival Analysis Techniques for Censored and Truncated Data. Springer, New York, NY, 1997; 417
21. Rayner HC, Pisoni RL, Gillespie BM et al. Creation, cannulation and survival of arterio-venous fistulae - data from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 63: 323-330
22. National Kidney Foundation. K/DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 [Suppl 3]: S192-S240
23. Locatelli F, Conte F, Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant 1998; 13: 1642-1644
24. Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619
25. Hecking E, Bragg-Gresham JL, Rayner HC et al. Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 100-107
26. Rayner HC, Pisoni RL, Bommer J et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 108-120